Skip to content

Clinical trials

Phase 2 Pancreatic Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2 Country / region: Taiwan Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20092
20141
20152
20173
20181
20193
20201
20212
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Unknown status4
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Health Research Institutes, Taiwan4
Hoffmann-La Roche2
Apollomics Inc.1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Boehringer Ingelheim1
Daiichi Sankyo1
Eli Lilly and Company1
Exelixis1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms23
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms4
Melanoma4
Ovarian Neoplasms4
Breast Neoplasms3
Head and Neck Neoplasms3
Lung Neoplasms3
Neoplasms3
Stomach Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.